NVR Return on Equity

NVR (NVR) currently reports a ROE of 30.49%. That is above the Healthcare sector average of 13.26%. Use the charts on this page to explore NVR's ROE history and peer comparisons.

NVR's ROE of 30.49% is higher than the Healthcare sector average of 13.26%. That is roughly 129.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but NVR's current 30.49% should be judged against Healthcare norms (sector average: 13.26%) and against NVR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 30.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.26%. From there, open related valuation or income-statement pages for NVR, and consider following NVR for alerts when major investors trade the stock.

NVR is classified in the Healthcare sector. On ROE, it currently shows 30.49% versus a sector average near 13.26%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVR with unrelated industries.